NCT02499328 2026-02-11Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & NeckAstraZenecaPhase 1/2 Completed340 enrolled 53 charts
NCT03421353 2024-08-21AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerAstraZenecaPhase 1 Completed76 enrolled